 | |
| Clinical data | |
|---|---|
| Trade names | Tolevamer |
| Pharmacokinetic data | |
| Bioavailability | None |
| Metabolism | None |
| Excretion | Faeces (100%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.167.553 |
| Chemical and physical data | |
| Formula | [C8H7SO3−] n |
Tolevamer is a medication developed to combat Clostridioides difficile associated diarrhea.[1] It is a potassium sodium polystyrene sulfonate. It was never marketed.
- ^ Hinkson PL, Dinardo C, DeCiero D, Klinger JD, Barker RH (June 2008). "Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile". Antimicrobial Agents and Chemotherapy. 52 (6): 2190–5. doi:10.1128/AAC.00041-08. PMC 2415796. PMID 18391047.